(Applicant's Description) This application requests renewal of the Cancer Center Support Grant (CCSG) of the NCI-designated Comprehensive Cancer Center (CCC) of Metropolitan Detroit at Wayne State University. The Programs of the CCC reflect the cancer needs of the greater Metropolitan Detroit area. This is an industrialized, urban and ethnically diverse community with a disproportionate number of medically disadvantaged, low socio-economic citizens. This CCC has a long-standing and extensive community network dedicated to the prevention, earlier detection and treatment of cancer, particularly of urban minority, African American and Arab American populations which experience disproportionate mortality from breast, prostate and aerodigestive cancers. Our grant requests support for six research programs, ten core facilities, and related administrative activity. The CCC's established cancer research programs are Breast Cancer; Developmental Therapeutics; Molecular Biology and Genetics; Population Studies and Prevention; Prostate Cancer; and Proteases. CCSG support is also requested for Cores in Biostatistics, Clinical Trials, Cell Resources, Genetics/Genomics, Human Tissues and Pathology, Confocal Microscopy, Flow Cytometry, Nutrition, Community-Based Research Management and Pharmacology. Our Programs are organized to integrate basic, translational, and clinical research with population research-based, cancer control activities. An asset of our Center is our Metropolitan Detroit Cancer Surveillance System, a member of the NCI-sponsored SEER registry system. The programs represent focused and targeted research efforts aimed at addressing the special and unique characteristics and needs of cancer patients in our community and region. During the grant period, particular emphasis is to be placed on research issues related to the early events in breast cancer, on development of prevention research in breast, prostate and lung cancer, on the translation of that research into the community, and on the development of novel therapeutic approaches to these high-morbidity and mortality cancers. In addition, strong basic research efforts in molecular genetics and in understanding mechanisms of invasion and metastasis will be foundations for both clinical and community-based research. The CCC will continue to foster multidisciplinary interactions and collaborations, and to utilize CCSG developmental funds and other support to recruit new investigators and to develop translational research programs that have a high potential for peer- reviewed funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA022453-23S1
Application #
6723503
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1988-04-01
Project End
2003-11-30
Budget Start
2001-12-01
Budget End
2003-11-30
Support Year
23
Fiscal Year
2003
Total Cost
$730,469
Indirect Cost
Name
Wayne State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Mills, Anne M; Peres, Lauren C; Meiss, Alice et al. (2018) Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol :
Vaishampayan, Ulka N; Podgorski, Izabela; Heilbrun, Lance K et al. (2018) Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res :
Sexton, Rachel E; Hachem, Ali H; Assi, Ali A et al. (2018) Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8:16008
Campbell, Douglas H; Lund, Maria E; Nocon, Aline L et al. (2018) Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. PLoS One 13:e0196017

Showing the most recent 10 out of 826 publications